Ross Kinstrie

946 total citations
18 papers, 712 citations indexed

About

Ross Kinstrie is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Ross Kinstrie has authored 18 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 8 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Ross Kinstrie's work include Chronic Myeloid Leukemia Treatments (11 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Ross Kinstrie is often cited by papers focused on Chronic Myeloid Leukemia Treatments (11 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Ross Kinstrie collaborates with scholars based in United Kingdom, United States and Switzerland. Ross Kinstrie's co-authors include Gary Sibbet, Pamela A. Lochhead, Vaughn Cleghon, Nick Morrice, Teeara Rawjee, Mhairi Copland, Tessa L. Holyoake, Karen Dunn, Mary T. Scott and David Vetrie and has published in prestigious journals such as Nature Communications, Blood and Molecular Cell.

In The Last Decade

Ross Kinstrie

18 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ross Kinstrie United Kingdom 11 397 217 129 126 118 18 712
Agata Klejman Poland 9 266 0.7× 237 1.1× 96 0.7× 43 0.3× 166 1.4× 17 586
Julia Procter United Kingdom 8 393 1.0× 102 0.5× 57 0.4× 67 0.5× 57 0.5× 9 601
Qihong Xu United States 11 500 1.3× 230 1.1× 78 0.6× 40 0.3× 152 1.3× 15 817
Sietske T. Bakker United States 11 822 2.1× 305 1.4× 126 1.0× 221 1.8× 101 0.9× 13 1.2k
Claire Dobson United Kingdom 10 349 0.9× 159 0.7× 67 0.5× 100 0.8× 40 0.3× 14 513
Irena N. Melnikova United States 12 729 1.8× 224 1.0× 127 1.0× 130 1.0× 41 0.3× 12 904
Yuhua Nong United States 7 382 1.0× 107 0.5× 237 1.8× 358 2.8× 127 1.1× 10 977
Michael Loubtchenkov Finland 7 558 1.4× 71 0.3× 102 0.8× 172 1.4× 85 0.7× 9 850
Dale Schaar United States 14 422 1.1× 147 0.7× 110 0.9× 73 0.6× 59 0.5× 32 710
Erikjan Rijkers Netherlands 13 674 1.7× 66 0.3× 61 0.5× 70 0.6× 101 0.9× 17 894

Countries citing papers authored by Ross Kinstrie

Since Specialization
Citations

This map shows the geographic impact of Ross Kinstrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Kinstrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Kinstrie more than expected).

Fields of papers citing papers by Ross Kinstrie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Kinstrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Kinstrie. The network helps show where Ross Kinstrie may publish in the future.

Co-authorship network of co-authors of Ross Kinstrie

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Kinstrie. A scholar is included among the top collaborators of Ross Kinstrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Kinstrie. Ross Kinstrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Scott, Mary T., Wei Liu, Rebecca Mitchell, et al.. (2024). Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease. Nature Communications. 15(1). 651–651. 7 indexed citations
2.
Scott, Mary T., Wei Liu, Rebecca Mitchell, et al.. (2021). Uncoupling p53 from an Embryonic Regulome Exhausts Quiescent CML Stem Cells through Inhibition of a HIF1alpha Molecular Program. Blood. 138(Supplement 1). 1541–1541. 1 indexed citations
3.
Kinstrie, Ross, Gillian A. Horne, Heather Morrison, et al.. (2020). Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy. Leukemia. 34(7). 1975–1975. 1 indexed citations
4.
Kinstrie, Ross, Gillian A. Horne, Heather Morrison, et al.. (2020). CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy. Leukemia. 34(6). 1613–1625. 50 indexed citations
5.
Kinstrie, Ross, et al.. (2019). Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML. Frontiers in Cell and Developmental Biology. 7. 136–136. 16 indexed citations
6.
Scott, Mary T., Koorosh Korfi, Peter Saffrey, et al.. (2016). Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition. Cancer Discovery. 6(11). 1248–1257. 99 indexed citations
7.
Kinstrie, Ross, Dimitris Karamitros, Nicolas Goardon, et al.. (2016). Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia. Blood Advances. 1(3). 160–169. 9 indexed citations
8.
Irvine, David, Bin Zhang, Ross Kinstrie, et al.. (2016). Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia. Scientific Reports. 6(1). 25476–25476. 58 indexed citations
9.
Sinclair, Amy, Mansi Shah, Mark E. Drotar, et al.. (2016). CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells. Blood. 128(3). 371–383. 53 indexed citations
10.
Horne, Gillian A., Heather Morrison, Victoria Campbell, et al.. (2016). Notch Pathway Activation Targets Leukemic Stem Cells in Chronic-Phase Chronic Myeloid Leukemia (CP-CML). Blood. 128(22). 3057–3057. 1 indexed citations
11.
Kinstrie, Ross, Gillian A. Horne, Heather Morrison, et al.. (2015). CD93 Is a Novel Biomarker of Leukemia Stem Cells in Chronic Myeloid Leukemia. Blood. 126(23). 49–49. 10 indexed citations
12.
Horne, Gillian A., Ross Kinstrie, & Mhairi Copland. (2015). Novel Drug Therapies in Myeloid Leukemia: a Patent Review. Pharmaceutical Patent Analyst. 4(3). 187–205. 14 indexed citations
13.
Kinstrie, Ross & Mhairi Copland. (2012). Targeting Chronic Myeloid Leukemia Stem Cells. Current Hematologic Malignancy Reports. 8(1). 14–21. 10 indexed citations
14.
Hansell, Chris, Chris Schiering, Ross Kinstrie, et al.. (2011). Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood. 117(20). 5413–5424. 71 indexed citations
15.
Kinstrie, Ross, Nathan Luebbering, Diego Miranda‐Saavedra, et al.. (2010). Characterization of a Domain That Transiently Converts Class 2 DYRKs into Intramolecular Tyrosine Kinases. Science Signaling. 3(111). ra16–ra16. 37 indexed citations
16.
Lochhead, Pamela A., Ross Kinstrie, Gary Sibbet, et al.. (2006). A Chaperone-Dependent GSK3β Transitional Intermediate Mediates Activation-Loop Autophosphorylation. Molecular Cell. 24(4). 627–633. 215 indexed citations
17.
Kinstrie, Ross, Pamela A. Lochhead, Gary Sibbet, Nick Morrice, & Vaughn Cleghon. (2006). dDYRK2 and Minibrain interact with the chromatin remodelling factors SNR1 and TRX. Biochemical Journal. 398(1). 45–54. 20 indexed citations
18.
Lochhead, Pamela A., et al.. (2003). dDYRK2: a novel dual-specificity tyrosine-phosphorylation-regulated kinase in Drosophila. Biochemical Journal. 374(2). 381–391. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026